Heather Behanna

In a report published Friday, Wedbush Securities analyst Heather Behanna assumed coverage on Noravax, Inc. (NASDAQ: NVAX) with an Outperform rating and $10.00 price target, down from $12.00. In the report, Wedbush Securities noted, “Novavax's analyst day next week should provide clarity on...

In a report published Friday, Wedbush Securities Heather Behanna initiated coverage on Mirati Therapeutics, Inc. (NASDAQ: MRTX) with an Outperform rating and $29.00 price target. In the report, Wedbush Securities noted, “Mirati Therapeutics is focused on development of oncology drugs for targeted...